<s>
Human_JJ African_JJ Trypanosomiasis_NN1 (_( HAT_NN1 )_) ,_, also_RR known_VVN as_II sleeping_JJ sickness_NN1 ,_, is_VBZ caused_VVN by_II protozoan_JJ parasites_NN2 of_IO the_AT genus_NN1 'Trypanosoma'_NN1 and_CC is_VBZ a_AT1 major_JJ cause_NN1 of_IO human_JJ ill_JJ health_NN1 and_CC mortality_NN1 ._. 
</s>
<s>
The_AT World_NN1 Health_NN1 Organisation_NN1 (_( WHO_NP1 )_) have_VH0 placed_VVN HAT_NN1 within_II the_AT ten_MC major_JJ health_NN1 problems_NN2 facing_VVG mankind_NN1 ,_, alongside_II malaria_NN1 ,_, cancer_NN1 ,_, and_CC heart_NN1 disease_NN1 (_( W.E_NP1 Kershaw_NP1 ,_, 1970_MC )_) ._. 
</s>
<s>
The_AT disease_NN1 itself_PPX1 is_VBZ caused_VVN by_II two_MC subspecies_NN of_IO the_AT hemoflagellates_NN2 (_( blood-_JJ motile_JJ )_) trypanosomes_VVZ ,_, the_AT East_NP1 African_JJ variant_NN1 caused_VVN by_II Trypanosoma_NP1 brucei_NN2 rhodesiense_VV0 and_CC the_AT West_NP1 African_JJ variant_NN1 caused_VVN by_II Trypanosoma_NP1 brucei_NN2 gambiense_VV0 ._. 
</s>
<s>
HAT_NN1 can_VM be_VBI found_VVN in_II 36_MC countries_NN2 in_II sub-_FU Saharan_NP1 Africa_NP1 ,_, which_DDQ shows_VVZ its_APPGE importance_NN1 as_II a_AT1 human_JJ pathogen_NN1 ._. 
</s>
<s>
During_II one_MC1 year_NNT1 around_II 300_MC -_- 500,000_MC people_NN develop_VV0 the_AT disease_NN1 ,_, there_EX are_VBR 50,000_MC deaths_NN2 ,_, and_CC 60_MC million_NNO people_NN are_VBR at_II risk_NN1 from_II the_AT disease_NN1 (_( WHO_NP1 ,_, 1986_MC )_) ._. 
</s>
<s>
The_AT disease_NN1 affects_VVZ people_NN living_VVG in_RP about_II one_MC1 third_MD of_IO Africa_NP1 ,_, being_VBG prevalent_JJ in_II areas_NN2 between_II latitudes_NN2 14_MC N_NNU and_CC 29_MC S_ZZ1 of_IO the_AT equator_NN1 ._. 
</s>
<s>
The_AT disease_NN1 affected_VVN a_AT1 smaller_JJR percentage_NN1 of_IO people_NN between_II 1949_MC and_CC 1965_MC ,_, but_CCB has_VHZ since_RR increased_VVN in_II recorded_JJ cases_NN2 ._. 
</s>
<s>
There_EX are_VBR many_DA2 possible_JJ reasons_NN2 for_IF such_DA an_AT1 increase_NN1 ,_, such_DA as_CSA the_AT breakdown_NN1 of_IO disease_NN1 surveillance_NN1 when_CS public_JJ health_NN1 systems_NN2 are_VBR disrupted_VVN ,_, for_REX21 example_REX22 ,_, changes_NN2 in_II climate_NN1 and_CC vegetation_NN1 ,_, migration_NN1 of_IO infected_JJ cattle_NN2 ,_, and_CC increases_VVZ in_II host_NN1 susceptibility_NN1 (_( Kuzoe_NP1 ,_, 1993_MC )_) ._. 
</s>
<s>
The_AT inadequate_JJ financial_JJ allocation_NN1 by_II the_AT local_JJ governments_NN2 has_VHZ also_RR played_VVN a_AT1 large_JJ factor_NN1 ._. 
</s>
<s>
The_AT disease_NN1 is_VBZ contracted_VVN via_II the_AT bite_NN1 of_IO the_AT blood-sucking_JJ tsetse_NN1 fly_NN1 of_IO the_AT glossina_NN1 species_NN which_DDQ remains_VVZ infective_JJ for_IF life_NN1 ._. 
</s>
<s>
The_AT tsetse_NN1 fly_NN1 contracts_VVZ the_AT parasite_NN1 via_II infected_JJ animals_NN2 such_II21 as_II22 cattle_NN2 ,_, and_CC then_RT acts_VVZ as_II a_AT1 vector_NN1 in_II which_DDQ T.b.rhodiense_NP1 and_CC T.b.gambiense_NP1 can_VM develop_VVI before_II being_VBG transferred_VVN to_II the_AT blood_NN1 system_NN1 in_II humans_NN2 ._. 
</s>
<s>
The_AT lifecycle_NN1 of_IO the_AT parasite_NN1 is_VBZ as_CSA described_VVN in_II the_AT following_JJ diagram_NN1 ._. 
</s>
<s>
A_AT1 factor_NN1 which_DDQ may_VM be_VBI important_JJ in_II determining_VVG whether_CSW31 or_CSW32 not_CSW33 the_AT disease_NN1 develops_VVZ after_II the_AT tsetse_NN1 fly_NN1 bite_NN1 occurs_VVZ is_VBZ the_AT number_NN1 of_IO metacyclic_JJ forms_NN2 that_CST are_VBR sinjected_VVN by_II the_AT insect_NN1 vector_NN1 ._. 
</s>
<s>
Fairbairn_VV0 &;_NULL Burt_NP1 (_( 1946_MC )_) concluded_VVD that_CST the_AT minimum_JJ infective_JJ dose_NN1 for_IF man_NN1 was_VBDZ 300-450_MCMC metacyclic_JJ trypanosomes_NN2 ._. 
</s>
<s>
Infection_NN1 occurs_VVZ in_II three_MC stages_NN2 ,_, the_AT first_MD being_VBG the_AT initial_JJ tsetse_NN1 bite.When_NNU the_AT tsetse_NN1 probes_VVZ the_AT subcutaneous_JJ tissues_NN2 ,_, trypanosomes_NN2 become_VV0 lodged_VVN and_CC create_VV0 a_AT1 'trypanosomal_JJ chancre'_NN1 ._. 
</s>
<s>
It_PPH1 takes_VVZ between_II five_MC to_II fifteen_MC days_NNT2 for_IF a_AT1 hard_JJ ,_, painful_JJ ,_, red_JJ nodule_NN1 to_TO appear_VVI on_II the_AT skin_NN1 ,_, with_IW heat_NN1 and_CC swelling_VVG that_CST spread_VV0 to_II the_AT surrounding_JJ tissues_NN2 ._. 
</s>
<s>
The_AT second_MD stage_NN1 is_VBZ referred_VVN to_II as_II the_AT haemolymphatic_JJ stage_NN1 ,_, in_II which_DDQ the_AT parasites_NN2 multiply_VV0 in_II the_AT individual_NN1 's_GE bloodstream_NN1 and_CC are_VBR then_RT carried_VVN to_II the_AT lymph_NN1 nodes_NN2 and_CC other_JJ organs_NN2 such_II21 as_II22 the_AT spleen_NN1 ,_, liver_NN1 ,_, heart_NN1 and_CC endocrine_JJ system_NN1 ._. 
</s>
<s>
Symptoms_NN2 for_IF this_DD1 stage_NN1 are_VBR fever_NN1 ,_, lymphadenopathy_NN1 ,_, and_CC pruritus_NN1 ._. 
</s>
<s>
After_CS a_AT1 few_DA2 weeks_NNT2 ,_, the_AT parasites_NN2 cross_VV0 the_AT blood_NN1 brain_NN1 barrier_NN1 (_( BBB_NP1 )_) to_TO invade_VVI the_AT CNS_NP1 ,_, known_VVN as_II the_AT meningoencephalitic_JJ stage_NN1 ._. 
</s>
<s>
The_AT distinction_NN1 between_II the_AT haemolytic_JJ and_CC meningoencephalitic_JJ stages_NN2 is_VBZ not_XX always_RR clear_JJ ,_, especially_RR in_II T._NP1 b._NNU rodesiense_NN1 infection_NN1 where_CS one_MC1 stage_NN1 may_VM run_VVI into_II the_AT next_MD (_( Atouguia_NP1 and_CC Kennedy_NP1 ,_, 2000_MC and_CC Kennedy_NP1 ,_, 2005_MC )_) ._. 
</s>
<s>
When_CS the_AT late_JJ stage_NN1 is_VBZ reached_VVN most_DAT regions_NN2 of_IO the_AT CNS_NP1 begin_VV0 to_II malfunction_NN1 ._. 
</s>
<s>
Once_RR this_DD1 occurs_VVZ ,_, the_AT individual_NN1 may_VM experience_VVI mental_JJ and_CC psychiatric_JJ symptoms_NN2 such_II21 as_II22 anxiety_NN1 ,_, irritability_NN1 and_CC hallucinations_NN2 and_CC delirium_NN1 ,_, a_AT1 wide_JJ range_NN1 of_IO motor_NN1 symptoms_NN2 such_II21 as_II22 tremors_NN2 ,_, muscle_NN1 twitching_VVG and_CC abnormal_JJ movements_NN2 ,_, painful_JJ peripheral_JJ sensory_JJ disturbances_NN2 ,_, visual_JJ problems_NN2 such_II21 as_II22 optic_NN1 neuritis_NN1 ,_, double_JJ vision_NN1 and_CC papilloedema_NN1 and_CC the_AT characteristic_JJ sleep_NN1 disturbances_NN2 that_CST originally_RR gave_VVD the_AT disease_NN1 its_APPGE other_JJ name_NN1 ,_, 'African_NN1 Sleeping_NN1 Sickness_NN1 '_GE ._. 
</s>
<s>
The_AT later_JJR symptoms_NN2 are_VBR generally_RR an_AT1 uncontrollable_JJ urge_NN1 to_TO sleep_VVI ,_, with_IW nocturnal_JJ insomnia_NN1 and_CC daytime_NNT1 somnolence_NN1 ._. 
</s>
<s>
If_CS untreated_JJ the_AT individual_NN1 will_VM progressively_RR deteriorate_VVI and_CC develop_VVI seizures_NN2 ,_, coma_NN1 and_CC incontinence_NN1 ,_, cerebral_JJ oedema_NN1 and_CC finally_RR die_VV0 (_( Kennedy_NP1 ,_, 2006_MC )_) ._. 
</s>
<s>
The_AT first_MD indication_NN1 on_II whether_CSW a_AT1 person_NN1 has_VHZ contracted_VVN HAT_NN1 is_VBZ the_AT geographical_JJ location_NN1 that_CST they_PPHS2 live_VV0 in_RP ,_, and_CC whether_CSW the_AT disease_NN1 is_VBZ endemic_JJ or_CC epidemic_NN1 ._. 
</s>
<s>
Because_CS the_AT early_JJ symptoms_NN2 are_VBR quite_RG non-specific_JJ ,_, other_JJ causes_NN2 of_IO disease_NN1 must_VM be_VBI excluded_VVN ._. 
</s>
<s>
Malaria_NN1 and_CC HAT_NN1 can_VM co-infect_VVI ,_, treating_VVG a_AT1 fever_NN1 with_IW anti-malarials_NN2 could_VM be_VBI wrongly_RR interpreted_VVN as_CSA successfully_RR treating_VVG a_AT1 person_NN1 who_PNQS has_VHZ HAT_NN1 ._. 
</s>
<s>
Other_JJ diseases_NN2 that_CST have_VH0 to_TO be_VBI excluded_VVN are_VBR leishmaniasis_NN1 ,_, human_JJ immunodeficiency_NN1 virus_NN1 (_( HIV_NP1 )_) infection_NN1 ,_, toxoplasmosis_NN1 ,_, tuberculosis_NN1 and_CC typhoid_JJ fever_NN1 (_( Atouguia_NP1 and_CC Kennedy_NP1 ,_, 2000_MC )_) ._. 
</s>
<s>
The_AT diagnosis_NN1 relies_VVZ upon_II demonstrating_VVG the_AT presence_NN1 of_IO trypanosomes_NN2 by_II microscopic_JJ examination_NN1 of_IO chancre_NN1 fluid_NN1 ,_, lymph_NN1 node_NN1 aspirates_NN2 ,_, blood_NN1 ,_, bone_NN1 marrow_NN1 ,_, or_CC ,_, in_II the_AT late_JJ stages_NN2 of_IO infection_NN1 ,_, cerebrospinal_JJ fluid_NN1 (_( CSF_NP1 )_) ._. 
</s>
<s>
For_IF blood_NN1 samples_NN2 ,_, these_DD2 include_VV0 centrifugation_NN1 followed_VVN by_II examination_NN1 of_IO the_AT buffy_JJ coat_NN1 ;_; mini_NN1 anion-exchange/centrifugation_FO ;_; and_CC the_AT Quantitative_JJ Buffy_JJ Coat_NN1 (_( QBC_NP1 )_) technique_NN1 ._. 
</s>
<s>
Spinal_JJ fluid_NN1 concentration_NN1 techniques_NN2 include_VV0 centrifugation_NN1 followed_VVN by_II examination_NN1 of_IO the_AT sediment_NN1 ._. 
</s>
<s>
Taking_VVG the_AT above_JJ into_II consideration_NN1 ,_, the_AT most_RGT efficient_JJ way_NN1 of_IO determining_VVG whether_CSW a_AT1 person_NN1 has_VHZ HAT_NN1 is_VBZ by_II identifying_VVG the_AT trypanosomes_NN2 in_II the_AT peripheral_JJ blood_NN1 or_CC lymph_NN1 node_NN1 aspirates_NN2 (_( if_CS the_AT lymph_NN1 nodes_NN2 are_VBR clinically_RR enlarged_VVN )_) using_VVG light_JJ microscopy_NN1 ._. 
</s>
<s>
In_II T._NP1 b._NNU rhodesiense_NN1 disease_NN1 it_PPH1 is_VBZ quite_RG easily_RR done_VDN due_II21 to_II22 the_AT persistent_JJ parasitaemia_NN1 ,_, but_CCB not_XX so_RG easily_RR in_II T._NP1 b._NNU gambiense_NN1 where_CS the_AT parasitaemia_NN1 is_VBZ cyclical_JJ ._. 
</s>
<s>
When_CS this_DD1 method_NN1 ca_VM n't_XX be_VBI applied_VVN ,_, serological_JJ testing_NN1 is_VBZ carried_VVN out_RP using_VVG the_AT card_NN1 agglutination_NN1 trypanosomiasis_NN1 test_NN1 (_( CATT_NP1 )_) (_( Truc_NP1 et_RA21 al._RA22 ,_, 2002_MC )_) ._. 
</s>
<s>
The_AT correct_JJ stage_NN1 diagnosis_NN1 of_IO HAT_NN1 is_VBZ critical_JJ for_IF the_AT treatment_NN1 of_IO the_AT disease_NN1 ,_, however_RR there_EX is_VBZ no_AT solid_JJ definition_NN1 ._. 
</s>
<s>
The_AT WHO_NP1 criteria_NN2 for_IF diagnosing_VVG the_AT late_JJ stages_NN2 of_IO disease_NN1 require_VV0 the_AT presence_NN1 of_IO trypanosomes_NN2 in_II the_AT CSF_NP1 and/or_CC a_AT1 white_JJ blood_NN1 cell_NN1 (_( WBC_NP1 )_) count_VV0 in_II the_AT CSF_NP1 of_IO 5/_FO l_ZZ1 (_( WHO_NP1 ,_, 1998_MC )_) ._. 
</s>
<s>
However_RR ,_, researchers_NN2 in_II West_ND1 Africa_NP1 with_IW T._NP1 b._NNU gambiense_NN1 disease_NN1 have_VH0 chosen_VVN to_TO use_VVI a_AT1 figure_NN1 of_IO 20/_FO l_ZZ1 in_II the_AT CSF_NP1 (_( Lejon_NP1 et_RA21 al._RA22 ,_, 2003_MC )_) ._. 
</s>
<s>
Raised_VVN intrathecal_JJ IgM_NN1 levels_NN2 in_II the_AT CSF_NP1 have_VH0 also_RR been_VBN identified_VVN in_II HAT_NN1 patients_NN2 with_IW late_JJ stage_NN1 disease_NN1 and_CC suggests_VVZ the_AT possibility_NN1 of_IO CSF_NP1 invasion_NN1 (_( Lejon_NP1 et_RA21 al._RA22 ,_, 2003_MC )_) ._. 
</s>
<s>
Therefore_RR a_AT1 latex_NN1 agglutination_NN1 test_NN1 for_IF IgM_NN1 amounts_NN2 has_VHZ been_VBN successfully_RR carried_VVN out_RP in_II field_NN1 conditions_NN2 and_CC has_VHZ the_AT potential_NN1 both_RR for_IF detecting_VVG and_CC monitoring_VVG HAT_NN1 ._. 
</s>
<s>
Currently_RR ,_, there_EX are_VBR no_AT vaccines_NN2 or_CC drugs_NN2 available_JJ to_TO prevent_VVI infection_NN1 of_IO HAT_NN1 ._. 
</s>
<s>
There_EX are_VBR however_RR ,_, drugs_NN2 available_JJ for_IF treating_VVG it_PPH1 ,_, but_CCB they_PPHS2 are_VBR scarce_JJ ,_, difficult_JJ to_TO administer_VVI ,_, and_CC sometimes_RT dangerous_JJ ._. 
</s>
<s>
One_MC1 of_IO the_AT original_JJ drugs_NN2 developed_VVN to_TO combat_VVI sleeping_JJ sickness_NN1 ,_, atoxyl_NN1 ,_, contained_VVD arsenic_NN1 and_CC caused_VVD blindness_NN1 in_II hundreds_NNO2 of_IO patients_NN2 in_II 1932_MC ._. 
</s>
<s>
A_AT1 drug_NN1 called_VVN melarsoprol_NN1 was_VBDZ developed_VVN to_TO prevent_VVI these_DD2 side_NN1 effects_NN2 ,_, and_CC is_VBZ currently_RR the_AT drug_NN1 of_IO choice_NN1 for_IF the_AT final_JJ stage_NN1 of_IO the_AT disease_NN1 ._. 
</s>
<s>
Suramin_NN1 ,_, pentamidine_VV0 ,_, and_CC berenil_NN1 have_VH0 been_VBN used_VVN to_TO treat_VVI ,_, and_CC sometimes_RT cure_VVI ,_, within_II the_AT haemolymphatic_JJ stages_NN2 of_IO the_AT infection_NN1 ._. 
</s>
<s>
The_AT drug_NN1 trybizine_NN1 has_VHZ tested_VVN successfully_RR for_IF East_NP1 African_JJ sleeping_JJ sickness_NN1 in_II research_NN1 animals_NN2 ._. 
</s>
<s>
Research_NN1 and_CC development_NN1 of_IO drugs_NN2 could_VM be_VBI considered_VVN minimal_JJ as_CSA they_PPHS2 are_VBR intended_VVN to_TO treat_VVI people_NN in_II under-developed_JJ countries_NN2 ,_, and_CC would_VM not_XX be_VBI considered_VVN to_TO be_VBI a_AT1 profitable_JJ venture_NN1 by_II many_DA2 pharmaceutical_JJ companies_NN2 ._. 
</s>
<s>
Eflornithine_VV0 ,_, an_AT1 anti-trypanosomal_JJ drug_NN1 has_VHZ been_VBN observed_VVN to_TO be_VBI effective_JJ in_II treating_VVG late-stage_JJ T.b.gambiense_NP1 infection_NN1 ._. 
</s>
<s>
The_AT drug_NN1 is_VBZ considered_VVN to_TO be_VBI expensive_JJ and_CC therefore_RR not_XX widely_RR available_JJ to_II areas_NN2 where_RRQ HAT_NN1 is_VBZ endemic_JJ ._. 
</s>
<s>
However_RR ,_, in_II March_NPM1 2001_MC ,_, the_AT World_NN1 Health_NN1 Organization_NN1 reached_VVD an_AT1 agreement_NN1 with_IW Bristol-Myers-Squibb_NP1 ,_, Dow_NP1 Chemical_NN1 ,_, Akorn_NP1 Manufacturing_NN1 ,_, and_CC the_AT French-German_JJ company_NN1 Aventis_NN1 to_TO produce_VVI and_CC donate_VVI 60,000_MC doses_NN2 of_IO eflornithine_NN1 to_TO help_VVI with_IW efforts_NN2 to_TO combat_VVI HAT_NN1 ._. 
</s>
<s>
Due_II21 to_II22 the_AT long_JJ symptom-free_JJ periods_NN2 following_VVG infection_NN1 ,_, periodic_JJ screening_NN1 would_VM be_VBI a_AT1 good_JJ way_NN1 to_TO go_VVI about_II detecting_VVG HAT_NN1 and_CC establish_VVI reliable_JJ estimates_NN2 of_IO incidence_NN1 ._. 
</s>
<s>
Currently_RR ,_, screening_NN1 is_VBZ more_RRR focused_VVN on_II high-risk_JJ areas_NN2 ._. 
</s>
<s>
As_II a_AT1 result_NN1 ,_, reported_VVD cases_NN2 under-represent_VV0 the_AT actual_JJ level_NN1 of_IO incidence_NN1 ._. 
</s>
<s>
As_CSA screening_VVG and_CC treatment_NN1 are_VBR decreased_VVN or_CC stopped_VVN in_II certain_JJ areas_NN2 ,_, the_AT disease_NN1 intensifies_VVZ ._. 
</s>
<s>
In_II 1999_MC ,_, 40,000-45,000_MCMC cases_NN2 were_VBDR reported_VVN ,_, and_CC only_RR three_MC to_II four_MC million_NNO people_NN were_VBDR screened_VVN out_II21 of_II22 an_AT1 estimated_JJ 60_MC million_NNO at_II risk_NN1 ._. 
</s>
<s>
(_( )_) ._. Economic_JJ and_CC social_JJ factors_NN2 make_VV0 effective_JJ vector-control_JJ strategies_NN2 difficult_JJ ._. 
</s>
<s>
There_EX are_VBR successful_JJ vector_NN1 control_NN1 programs_NN2 ,_, but_CCB exist_VV0 in_RP less_DAR than_CSN 2%_NNU of_IO the_AT areas_NN2 where_RRQ the_AT disease_NN1 is_VBZ endemic_JJ (_( )_) ._. 
</s>
<s>
Ground_NN1 spraying_NN1 of_IO insecticides_NN2 ,_, aerial_NN1 spraying_NN1 ,_, the_AT use_NN1 of_IO cloth_NN1 baits_NN2 (_( cloth_NN1 sprayed_VVN with_IW insecticide_NN1 )_) ,_, and_CC the_AT use_NN1 of_IO live_JJ baits_NN2 (_( cattle_NN2 sprayed_VVN with_IW insecticide_NN1 )_) have_VH0 shown_VVN some_DD success_NN1 ._. 
</s>
<s>
Transegenic_JJ techniques_NN2 ,_, such_II21 as_II22 introducing_VVG into_II tsetse_NN1 flies_VVZ foreign_JJ genes_NN2 that_CST will_VM restrict_VVI the_AT tsetse_NN1 flies_VVZ ability_NN1 to_TO survive_VVI ,_, reproduce_VVI ,_, or_CC transmit_VVI pathogens_NN2 ,_, appear_VV0 to_TO be_VBI a_AT1 promising_JJ area_NN1 in_II research_NN1 for_IF the_AT near_JJ future_NN1 ._. 
</s>
